Old Web
English
Sign In
Acemap
>
Paper
>
Ibrutinib Plus Venetoclax for First-line Treatment of Chronic Lymphocytic Leukemia
Ibrutinib Plus Venetoclax for First-line Treatment of Chronic Lymphocytic Leukemia
2021
Nitin Jain
Michael J. Keating
Philip A Thompson
Alessandra Ferrajoli
Jan A. Burger
Gautam Borthakur
Koichi Takahashi
Zeev Estrov
Koji Sasaki
Nathan Fowler
Tapan M. Kadia
Marina Konopleva
Yesid Alvarado
Musa Yilmaz
Courtney D. DiNardo
Prithviraj Bose
Maro Ohanian
Naveen Pemmaraju
Elias Jabbour
Rashmi Kanagal Shamanna
Keyur P. Patel
Wei Wang
Jeffrey L. Jorgensen
Sa A. Wang
Naveen Garg
Xuemei Wang
Chongjuan Wei
Nichole Cruz
Ana Ayala
William Plunkett
Hagop M. Kantarjian
Varsha Gandhi
William G. Wierda
Keywords:
Oncology
Venetoclax
Internal medicine
first line treatment
Chronic lymphocytic leukemia
Ibrutinib
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]